-
CSCI Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
COSCIENS Biopharma (CSCI)
Company Profile
Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 7 |
Opened positions | 7 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 53.57 mm |
Total shares | 235.69 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Goodwood | 221.57 k | $851.00 k |
NA.R National Bank of Canada | 5.80 k | $21.74 mm |
Federation des caisses Desjardins du Quebec | 4.54 k | $16.89 mm |
TD Waterhouse Canada | 3.72 k | $13.81 mm |
Advisor | 50.00 | $185.00 k |
Truvestments Capital | 22.00 | $83.00 k |
Planning Capital Management | 2.00 | $8.00 k |
Proequities | 0.00 | $0.00 |